Know Labs Faces Delisting Concerns

TL;DR

KNOW might get delisted, check the details.

AI Summary

Know Labs, Inc. filed an 8-K on December 11, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The filing also includes other events and financial statements and exhibits. The company's fiscal year ends on September 30.

Why It Matters

This filing indicates potential issues with Know Labs' continued listing on an exchange, which could impact its stock trading and investor confidence.

Risk Assessment

Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading and overall financial health.

Key Players & Entities

• KNOW LABS, INC. (company) — Registrant
• December 10, 2024 (date) — Earliest event reported
• December 11, 2024 (date) — Filing date
• 001-37479 (company) — Commission File Number
• 90-0273142 (company) — IRS Employer Identification Number
• Nevada (company) — State of incorporation
• September 30 (date) — Fiscal year end

FAQ

Key Financial Figures

• $0.001 K — ch registered Common Stock, par value $0.001 KNW NYSE American LLC Indicate by chec
• $4.0 million — , which require stockholders' equity of $4.0 million or more if the Company has reported los
• $6.0 million — f the four most recent fiscal years and $6.0 million or more if the Company has reported los
• $4.6 million — he Company had stockholders' deficit of $4.6 million and has had losses in the most recent f

Filing Documents

• knwn_8k.htm (8-K) — 30KB
• knwn_ex991.htm (EX-99.1) — 9KB
• knwn_ex991img2.jpg (GRAPHIC) — 4KB
• 0001654954-24-015377.txt ( ) — 171KB
• knwn-20241210.xsd (EX-101.SCH) — 6KB
• knwn-20241210_lab.xml (EX-101.LAB) — 14KB
• knwn-20241210_cal.xml (EX-101.CAL) — 1KB
• knwn-20241210_pre.xml (EX-101.PRE) — 9KB
• knwn-20241210_def.xml (EX-101.DEF) — 2KB
• knwn_8k_htm.xml (XML) — 4KB

01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On December 10, 2024, Know Labs, Inc. (the "Company") received notice from the NYSE American LLC ("NYSE American") that it had accepted the Company's plan to regain compliance with the NYSE American continued listing standards and granted a plan period through March 27, 2026 ("Extension Date"). As previously disclosed on September 27, 2024, the Company received a letter from the NYSE American stating that the Company was not in compliance with the continued listing standards set forth in Sections 1003(a)(ii) and 1003(a)(iii) of the NYSE American Company Guide, which require stockholders' equity of $4.0 million or more if the Company has reported losses from continuing operations and/or net losses in three of the four most recent fiscal years and $6.0 million or more if the Company has reported losses from continuing operations and/or net losses in its five most recent fiscal years, respectively. As of June 30, 2024, the Company had stockholders' deficit of $4.6 million and has had losses in the most recent five fiscal years ended September 30, 2023. During the plan period, the Company will be subject to periodic review by the NYSE American to determine if it is making progress consistent with the plan. If the Company does not regain compliance with the NYSE American listing standards by the Extension Date, or if the Company does not make sufficient progress consistent with its plan, then the NYSE American may initiate delisting proceedings. The Company's common stock will continue to be listed on the NYSE American during the plan period pursuant to an extension, subject to the Company's compliance with the other listing requirements of the NYSE American. The Company's receipt of such notification from the NYSE American does not affect the Company's business, operations or reporting requirements with the U.S. Securities and Exchange Commission. The Compa

01 Other Events

Item 8.01 Other Events On December 11, 2024, the Company issued a press release regarding the NYSE American's acceptance of the Company's compliance plan, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Forward-Looking Statements

Forward-Looking Statements This report contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, but not limited to, statements that are based upon management's current expectations, assumptions, estimates, projections and beliefs. The use of words such as, but not limited to, "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "potential," "predict," "project," "should," "target," "will," or "would" and similar words or expressions are intended to identify forward-looking statements. These statements include, but are not limited to, statements regarding the impact of the Letter and the Company's ability to comply with the continued listing requirements of the NYSE American. These statements involve risks, uncertainties and other factors that may cause actual results or achievements to be materially different and adverse from those expressed in or implied by the forward-looking statements. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. Other risks relating to the Company's business, including risks that could cause results to differ materially from those projected in the forward-looking statements in this report, are detailed in the Company's latest Form 10-K filing with the Securities and Exchange Commission, especially under the heading "Risk Factors." The forward-looking statements in this report speak only as of this date, and the Company disclaims any intent or obligation to revise or update publicly any forward-looking statement except as required by law.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits (d) Exhibits . Exhibit No. Description 99.1 Press Release, dated December 11, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 11, 2024 KNOW LABS, INC. /s/ Ronald P. Erickson Name: Ronald P. Erickson Title: Chairman of the Board 3

View Full Filing

View this 8-K filing on SEC EDGAR